ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,338.40
0.19%
S&P ASX All Technology
4,030.00
-1.68%
Brent Oil
76.305
0.64%
US Dollar vs AUD
1.56128
-1.03%
Bitcoin
98,319.46
1.75%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Gilead Sciences Inc (GIS) Share Price

Gilead Sciences Inc

Gilead Sciences Inc (GIS)

Gismondi 1754 SpA
General Mills Inc
Genesis Metals Corp
104.78
1.52
(1.47%)
Closed 21 February 8:00AM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
104.78
Bid
104.72
Offer
104.90
Volume
4,100
102.74 Day's Range 104.78
57.18 52 Week Range 104.78
Market Cap
130.584B
Previous Close
103.26
Open
102.74
Last Trade
100
@
104.74
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
5,449
Shares Outstanding
1,246,265,857
Dividend Yield
3.17%
PE Ratio
24.21
Earnings Per Share (EPS)
4.55
Revenue
27.12B
Net Profit
5.67B

About Gilead Sciences Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.gilead.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Gilead Sciences Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 103.26 €. Over the last year, Gilead Sciences shares have traded in a share price range of 57.18 € to 104.78 €.

Gilead Sciences currently has 1,246,265,857 shares in issue. The market capitalisation of Gilead Sciences is 128.69 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 24.21.

Ask ADVFN Intelligence (AI)

GIS Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
15.785.8383838383899104.7898.56154100.87263332DE
415.4417.282292366289.34104.7885.37628995.53781414DE
1216.5918.811656650488.19104.7885.25544991.54713129DE
2637.6256.01548540867.16104.7866.58505385.64969201DE
5239.0259.336982968465.76104.7857.18504375.02243032DE
15650.5293.107261334354.26104.7852.06437072.8680994DE
26042.7668.945501451162.02104.7846.1651050566.03567714DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?
The current share price of Gilead Sciences is 104.78 €
How many Gilead Sciences shares are in issue?
Gilead Sciences has 1,246,265,857 shares in issue
What is the market cap of Gilead Sciences?
The market capitalisation of Gilead Sciences is EUR 128.69B
What is the 1 year trading range for Gilead Sciences share price?
Gilead Sciences has traded in the range of 57.18 € to 104.78 € during the past year
What is the PE ratio of Gilead Sciences?
The price to earnings ratio of Gilead Sciences is 24.21
What is the cash to sales ratio of Gilead Sciences?
The cash to sales ratio of Gilead Sciences is 5.06
What is the reporting currency for Gilead Sciences?
Gilead Sciences reports financial results in USD
What is the latest annual turnover for Gilead Sciences?
The latest annual turnover of Gilead Sciences is USD 27.12B
What is the latest annual profit for Gilead Sciences?
The latest annual profit of Gilead Sciences is USD 5.67B
What is the registered address of Gilead Sciences?
The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Gilead Sciences website address?
The website address for Gilead Sciences is www.gilead.com
Which industry sector does Gilead Sciences operate in?
Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
K1SNKlondike Silver Corporation
0.0265 €
(130.43%)
147k
E3O1Nexoptic Technology Corp
0.0195 €
(62.50%)
217
1FGFibroGen Inc
0.7968 €
(46.90%)
49.72k
K8DWellfield Technologies Inc
0.0176 €
(46.67%)
940.27k
HOOHerbalife Ltd
7.826 €
(45.03%)
26.89k
CNWCodon AG
0.015 €
(-45.45%)
5.28k
CFJACeres Power Holdings Plc
0.9855 €
(-38.14%)
465.04k
8EMEditas Medicine Inc
1.967 €
(-35.82%)
54.07k
06MAMaterialise Nv
5.75 €
(-35.03%)
18.18k
FEXFerrexpo PLC
0.79 €
(-34.17%)
1.38M
VAR1Varta AG
1.85 €
(23.33%)
8.98M
D7GNel ASA
0.2099 €
(-1.69%)
3.65M
3CPXiaomi Corporation
6.22 €
(0.31%)
3.11M
34Q0Quantum eMotion Inc
0.595 €
(21.93%)
2.29M
RQ0DWave Quantum Inc
7.07 €
(12.51%)
2.19M

Discussion

View Full Feed
ruskie1 ruskie1 3 minutes ago
Role model ..oh , you don’t mean the guy that’s saving our country billions of dollars soon to be trillions… and will be possibly dispersing it to all the Americans, whose tax dollars were abused

Oh, that guy
KBLB
Str8t-talk Str8t-talk 3 minutes ago
in case anyone is interested Kevin Williams made $160k profit in 2024 from selling stock.. supplement for salary? Probably!
VPLM
work-n-hard work-n-hard 3 minutes ago
MLGO: From 1.11 to 2.99 and still going
MLGO
bbotcs bbotcs 3 minutes ago
Gmenfan: Only one Republican voted against Patel--Senator Collins. Murkowski is no Republican. Sen. Collins excuse was lame, and she should be ashamed of herself.
Let's see what these hags say when Patel uncovers the Bureau's involvement with J6.
Whistleblowers should be coming ou
TheDane TheDane 3 minutes ago
Good article. I like this…
“…potentially reaching $140 per share in the medium term.”
SMCI
janice shell janice shell 3 minutes ago
Thank you so much for the article about the new Egyptian tomb! I've always loved reading about Egyptian funerary practices. And mummies. Especially mummies:

Ancient Egyptian mummies still smell nice, study finds

https://www.bbc.com/news/articles/crr0ypp84x9o
IHuser IHuser 3 minutes ago
imo...what is the practical application or lure for anything Tesla besides making the investors richer...? They are a totally impractical piece of dung....and spy on you....DEFUND EV'S.
TSLA
Yo-Yo Yo-Yo 4 minutes ago
In the Trasfer Portal ,hoping Ohio State picks CMMB @ the $1.67 , watching for bottom of the pile, don't wanna fumble here 
CMMB
Coreton Coreton 4 minutes ago
Yep.  Once cheated twice shy.  I don't blame them, they took a massive hit.  I just had. Little but still not happy how it went down.  Such is investing.  

I ran some numbers last year on this water company.  It really was mismanaged.  Lots of profits to be made.  

Cor.
ECGS
janice shell janice shell 4 minutes ago
Really. Musk turned up at CPAC with a chain saw. He is so VERY tiresome. And he was whining about immigrants. He is one, and I agree that he is one who needs to GO.
eastunder eastunder 4 minutes ago
Earnings updated 2-20-25

AI 2-21 A

ZM 2-24 A

KDP 2-25 B

SNOW 2-26 A
CRM 2-26 A
NVDA 2-26 A

PLUG 2-27 B ?
RKT 2-27 A

CRWD 3-4 A

IRBT 3-12 B
PATH 3-12 A

U
AMD AMZN CMG
PEACHMAN PEACHMAN 5 minutes ago
https://impactfusionbrands.com/knowledge-base/suraec-report-submitted-to-louisiana-house-committee-on-agriculture-02-07-2025/
IFUS
hbhmb hbhmb 5 minutes ago
You are right I am an awful investor
Of course why would anyone choose to be happy - what a silly thing to do. I am sure it is much more enjoyable being a curmudgeon . I think it is time for you to write a small booklet on investing, you could call it “ Cecil B and his pearls of wisdom .
AIAD
price_and_volume price_and_volume 5 minutes ago
Well they been cranking out the 8-Ks...
Anyone have any thoughts on that? I tend to not believe in much other than price-action.

Who what why?

Beats me.

Pick yer spots take yer shots. It works or it doesn't, and don't overstay.

GL!
NEWH
trade15 trade15 5 minutes ago
Janice
Better to have baked sweet potatoes smothered in butter with salt and pepper. I have them quite often due to having Lyme disease.
Trade15
noradio noradio 5 minutes ago
Kash Patel confirmed as FBI director, let's hope he goes after the biggest grift in world history, naked shorting.
SC8 SC8 5 minutes ago
Again, why blame FDA for MK's failures?
RDGL
Value_Investor Value_Investor 6 minutes ago
SSHT ever hit $4.1 or Eye-Popping-High $758,104,239.30 Market Value (MV) recently! Do you know why it could hit such high MV as a Empty Shell stock? TIA!

Anyway, buying SSHT at $4.1 = buying its Same CI-tier Red-Hot Bitcoin-Mining OTC peer (VTXB) at $0.2143 which is 2143 Tim
VTXB
3Angels120702 3Angels120702 6 minutes ago
What if you knew that Schlenk only paid for the pilot?
MWWC
SkyLimit2022 SkyLimit2022 6 minutes ago
LC,

Yes, the Medicine Maker sounds like a prestigious publication 😶

… But it’s also great to see DCVax-L mentioned here too:

https://investorshub.advfn.com/uimage/uploads/2024/10/2/ztpvlIMG_9702.jpeg
https://www.nature.com/articles/s41467-0
NWBO
zab zab 6 minutes ago
Trump's dementia is on full display.  He wants to own 1/2 of the mineral rights to Ukraine.  Can America sell trump?
noradio noradio 6 minutes ago
Kash Patel confirmed as new FBI director, very possible some of the shorts on this board will regret their decision to vote for Trump. 😅
DBMM
SC8 SC8 7 minutes ago
Yep, always soon for RDGL, always soon. MK flushes nearly a decade down toilet, failed to get Radiogel to market before the patents expired, but it's always soon for RDGL.
RDGL
Teddytropics Teddytropics 7 minutes ago
Great post.

A relief to get some information in the constructive guessing game.

I am not going to bother reading my replies below.

I couldn't stomach digesting the same claptrap.

Fascinating to see what it is actually like. I thought it wo
MWWC
learningcurve2020 learningcurve2020 7 minutes ago
Yeah, everything else is pretty apparent. 🙄
NWBO

Your Recent History

TG
GIS
Gilead Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads